EXECUTIVE
PROFILES
Dr.
Janet Greeson, Chairman, President and CEO, led the
bold initiative that transformed Samaritan from a "one
drug" Company to an innovative "Drug Development
Pipeline" Biopharmaceutical Company. She strategically
created a long-term value and growth model, with the
Samaritan/Georgetown University collaboration; and intends
to duplicate this growth model with other top tier Universities,
as a solid strategy to continually build Samaritan's
value and sustain its future profitability.
Dr.
Greeson is a successful healthcare professional with
over two decades of corporate experience focused on
emerging growth situations, leadership development,
and mergers and acquisitions. Although she has worked
with Samaritan for nine years, as CEO for the past four
years she has demonstrated a relentless perseverance
and determination to succeed in the face of unrelenting
change. She is extremely motivated and equipped to attack
problems and seize realistic opportunities, with capability,
courage and confidence.
Dr.
Greeson is a co-inventor of 18 patent applications,
and presently has nine "peer reviewed" journal
publications. She is a best selling author of "It's
Not What You Are Eating, It's What's Eating You";
and a renowned public speaker, whose guest appearances
on numerous radio and TV Talk shows, has opened the
door to tell the Samaritan story, in a concise and professional
manner.
Dr.
Greeson is an experienced growth "Model" developer.
In the past, Dr. Greeson developed model "Addiction
Rehab Programs" for the US Navy, and went on privately,
to develop and grow a nationwide "inpatient treatment
program model" which she later sold to Columbia/HCA
(NYSE:COL).
Dr.
Greeson has an eclectic past, once working with Mother
Theresa and was privileged to be the U.S. Congressional
Nominee for the State of Nevada in 1994, winning the
primary without spending a dollar to campaign. She currently
fulfills her altruistic energies with the Samaritan
Innovative Science Foundation.
Dr.
Greeson holds a BA, from Florida Technological University
1978; an MA from Rollins College 1979; a PhD from Columbia
Pacific University 1987.
Dr.
Greeson devotes substantially all of her time to the
affairs of Samaritan Pharmaceuticals. |